Givlaari (givosiran), an approved therapy for acute hepatic porphyria (AHP), was associated with several potentially new safety signals not included in the therapy’s prescribing information, according to a large real-world safety analysis. By analyzing more than 1,200 reports of adverse events associated with Givlaari in a U.S. drug safety…
Discussion
Lately, there has been more attention directed my way than I am entirely comfortable with. Recently, it came after my team shared behind-the-scenes photos from filming a segment for the morning television show “The Balancing Act” in the office of the United Porphyrias Association (UPA), where I serve…
Discussion
Treatment with hemin — an iron-containing medication derived from red blood cells — effectively reduced the frequency of symptomatic attacks in a middle-aged woman with acute intermittent porphyria (AIP), and also mitigated a decline in her kidney function. According to the researchers, the use of hemin, sometimes prescribed for…
Discussion
Acute intermittent porphyria (AIP) is associated with a higher prevalence of high blood pressure (hypertension) and heart structural changes, according to a recent study. The results suggest that age, body mass index (BMI) — a measure of body fat based on a weight-to-height ratio — and a history of…
Becoming educated and informed about porphyria is a good first step. Here you’ll find general information about the disease, including the types, diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of some of our columnist’s words of wisdom to help you along on your porphyria journey.
There is no cure for porphyria yet, but there are therapies that can help manage the disease. Here you can find more information about some of the approved treatments for porphyria.
Get regular updates to your inbox.
